Adaptive Biotechnologies translates scale and precision of the adaptive immune system into products to diagnose and treat disease.
Adaptive Biotechnologies was founded in 2009 by Chad Robins, Christopher Carlson, Harlan Robins.
1282 health care and life sciences companies are in the directory, 61 of them in the same 501-1,000 employee range and 12 based in Greater Seattle Area.
Adaptive Biotechnologies may be growing as indicated by a reported 12 percent revenue growth for Q2, which is a quantitative indicator of financial health. Additionally, the volume of the ClonoSeq test has increased, suggesting a rise in product demand. Furthermore, the company is profiled in a report forecasting the global MRD (Minimal Residual Disease) testing market, where Adaptive Biotechnologies is expected to benefit from a rising number of clinical trials and treatment decisions, indicating a positive outlook in its industry.
“Adaptive Biotechnologies is harnessing the immune system to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine.” adaptivebiotech.com
Adaptive Biotechnologies has a 501-1,000 person team and operates in biotechnology, listed under Greater Seattle Area, and has been around since 2009. Its website drew about 5,937 visits in the latest month measured and its founders are Chad Robins, Christopher Carlson and Harlan Robins.
101-250 employees · adimab.com
101-250 employees · aveooncology.com
101-250 employees · abivax.com
11-50 employees · a-biodesign.com
11-50 employees · alxoncology.com
11-50 employees · aardvarktherapeutics.com
11-50 employees · acernatec.com
51-100 employees · acrivon.com
51-100 employees · 4basebio.com
11-50 employees · advancells.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.